This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

Jannick Bendtsen, PhD
CEO at PipeBio
Speaker

Profile

Jannick is co-founder and CEO of PipeBio, a leading bioinformatics platform for antibody drug discovery and peptide therapeutics. He has nearly 20 years of experience in highly successful bioinformatics companies such as CLC bio and Geneious and an impressive scientific profile with more than 10k citations,. He leads an innovative company aiming to help cure diseases like cancer and COVID-19 by offering a cloud-based bioinformatics platform for faster antibody development.

Agenda Sessions

  • Automated Bioinformatics Pipelines for Rapid In Silico Analysis – A Case Study of Versatile Antibody Assessment and In Vitro Selection

    15:30